Holding RIPK1 on the Ubiquitin Leash in TNFR1 Signaling

Trends in Cell Biology

Volumn 26, Issue 6, 2016, Pages 445-461

  Peltzer, Nieves ^a   Darding, Maurice ^a   Walczak, Henning ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CIAP1 2; LUBAC; Necroptosis; RIPK1; TNFR1; Ubiquitination

Indexed keywords

CASPASE 8; EFFECTOR CASPASE; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; INTERLEUKIN 1BETA; LINEAR UBIQUITIN CHAIN ASSEMBLY COMPLEX PROTEIN; PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RIP KINASE 1; SUCCINATE DEHYDROGENASE (UBIQUINONE); TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 5; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

ADAPTIVE IMMUNITY; APOPTOSIS; CELL DEATH; GENE ACTIVATION; GENE DELETION; GENE INDUCTION; INNATE IMMUNITY; NECROPTOSIS; OLIGOMERIZATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION; ANIMAL; HUMAN; METABOLISM;

ANIMALS; CELL DEATH; HUMANS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 84968919520     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2016.01.006     Document Type: Review

References (112)

1. Komander D., Rape M. The ubiquitin code. Annu. Rev. Biochem. 2012, 81:203-229.
2. Schmukle A.C., Walczak H. No one can whistle a symphony alone - how different ubiquitin linkages cooperate to orchestrate NF-kappaB activity. J. Cell Sci. 2012, 125:549-559.
3. Micheau O., Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003, 114:181-190.
4. Bertrand M., et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 2008, 30:689-700.
5. Dynek J.N., et al. c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J. 2010, 29:4198-4209.
6. Gerlach B., et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 2011, 471:591-596.
7. Varfolomeev E., et al. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFα)-induced NF-kappaB activation. J. Biol. Chem. 2008, 283:24295-24299.
8. Ikeda F., et al. SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappaB activity and apoptosis. Nature 2011, 471:637-641.
9. Tokunaga F., et al. SHARPIN is a component of the NF-kappaB-activating linear ubiquitin chain assembly complex. Nature 2011, 471:633-636.
10. Tokunaga F., et al. Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat. Cell Biol. 2009, 11:123-132.
11. Haas T.L., et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 2009, 36:831-844.
12. Wertz I.E., et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 2004, 430:694-699.
13. Enesa K., et al. NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling. J. Biol. Chem. 2008, 283:7036-7045.
14. Brummelkamp T.R., et al. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 2003, 424:797-801.
15. Kovalenko A., et al. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 2003, 424:801-805.
16. Draber P., et al. LUBAC-recruited CYLD and A20 regulate gene activation and cell death by exerting opposing effects on linear ubiquitin in signaling complexes. Cell Rep. 2015, 13:2258-2272.
17. Dickens L.S., et al. A death effector domain chain DISC model reveals a crucial role for caspase-8 chain assembly in mediating apoptotic cell death. Mol. Cell 2012, 47:291-305.
18. Cho Y.S., et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009, 137:1112-1123.
19. Dondelinger Y., et al. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep. 2014, 7:971-981.
20. Wang H., et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol. Cell 2014, 54:133-146.
21. Hildebrand J.M., et al. Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:15072-15077.
22. Kaiser W.J., et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 2011, 471:368-372.
23. Oberst A., et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 2011, 471:363-367.
24. Zhang H., et al. Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 2011, 471:373-376.
25. Dillon C.P., et al. Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Rep. 2012, 1:401-407.
26. Varfolomeev E.E., et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 1998, 9:267-276.
27. Sakamaki K., et al. Ex vivo whole-embryo culture of caspase-8-deficient embryos normalize their aberrant phenotypes in the developing neural tube and heart. Cell Death Differ. 2002, 9:1196-1206.
28. Boatright K.M., et al. Activation of caspases-8 and -10 by FLIP(L). Biochem. J. 2004, 382:651-657.
29. Micheau O., et al. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J. Biol. Chem. 2002, 277:45162-45171.
30. Pop C., et al. FLIP(L) induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity. Biochem. J. 2011, 433:447-457.
31. Feng S., et al. Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell Signal. 2007, 19:2056-2067.
32. Kelliher M.A., et al. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 1998, 8:297-303.
33. Rickard J.A., et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 2014, 157:1175-1188.
34. Dillon C.P., et al. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 2014, 157:1189-1202.
35. Holler N., et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 2000, 1:489-495.
36. Kaiser W.J., et al. RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:7753-7758.
37. Roderick J.E., et al. Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosis. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:14436-14441.
38. Newton K., et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 2014, 343:1357-1360.
39. Berger S.B., et al. Cutting edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. J. Immunol. 2014, 192:5476-5480.
40. Takahashi N., et al. RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. Nature 2014, 513:95-99.
41. Dannappel M., et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 2014, 513:90-94.
42. Welz P.S., et al. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 2011, 477:330-334.
43. Orozco S., et al. RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. Cell Death Differ. 2014, 21:1511-1521.
44. Darding M., Meier P. IAPs: guardians of RIPK1. Cell Death Differ. 2012, 19:58-66.
45. Silke J., Meier P. Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation. Cold Spring Harb. Perspect. Biol. 2013, 5:a008730.
46. Mahoney D.J., et al. Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:11778-11783.
47. Silke J., Vaux D.L. IAP gene deletion and conditional knockout models. Semin. Cell Dev. Biol. 2015, 39:97-105.
48. Vince J., et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 2007, 131:682-693.
49. Tenev T., et al. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol. Cell 2011, 43:432-448.
50. Feoktistova M., et al. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol. Cell 2011, 43:449-463.
51. Geserick P., et al. Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. J. Cell Biol. 2009, 187:1037-1054.
52. Conze D.B., et al. Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol. Cell. Biol. 2005, 25:3348-3356.
53. Conte D., et al. Inhibitor of apoptosis protein cIAP2 is essential for lipopolysaccharide-induced macrophage survival. Mol. Cell. Biol. 2006, 26:699-708.
54. Moulin M., et al. IAPs limit activation of RIP kinases by TNF receptor 1 during development. EMBO J. 2012, 31:1679-1691.
55. Heard K.N., et al. cIAP2 supports viability of mice lacking cIAP1 and XIAP. EMBO J. 2015, 34:2393-2395.
56. Rodrigue-Gervais I.G., et al. Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival. Cell Host Microbe 2014, 15:23-35.
57. Zinngrebe J., et al. Ubiquitin in the immune system. EMBO Rep. 2014, 15:28-45.
58. Rieser E., et al. Linear ubiquitination: a newly discovered regulator of cell signalling. Trends Biochem. Sci. 2013, 38:94-102.
59. Walczak H., et al. Generation and physiological roles of linear ubiquitin chains. BMC Biol. 2012, 10:23.
60. Shimizu Y., et al. Linear ubiquitination in immunity. Immunol. Rev. 2015, 266:190-207.
61. Peltzer N., et al. HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death. Cell Rep. 2014, 9:153-165.
62. Boisson B., et al. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat. Immunol. 2012, 13:1178-1186.
63. Boisson B., et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J. Exp. Med. 2015, 212:939-951.
64. HogenEsch H., et al. Absence of Peyer's patches and abnormal lymphoid architecture in chronic proliferative dermatitis (cpdm/cpdm) mice. J. Immunol. 1999, 162:3890-3896.
65. Gijbels M.J., et al. Maintenance of donor phenotype after full-thickness skin transplantation from mice with chronic proliferative dermatitis (cpdm/cpdm) to C57BL/Ka and nude mice and vice versa. J. Invest. Dermatol. 1995, 105:769-773.
66. Rickard J.A., et al. TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice. eLife 2014, 3:e03464.
67. Kumari S., et al. Sharpin prevents skin inflammation by inhibiting TNFR1-induced keratinocyte apoptosis. eLife 2014, 3:e03422.
68. Panayotova-Dimitrova D., et al. cFLIP regulates skin homeostasis and protects against TNF-induced keratinocyte apoptosis. Cell Rep. 2013, 5:397-408.
69. de Almagro M.C., et al. Cellular IAP proteins and LUBAC differentially regulate necrosome-associated RIP1 ubiquitination. Cell Death Dis. 2015, 6:e1800.
70. Yeh W.C., et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 1998, 279:1954-1958.
71. Zhang J., et al. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 1998, 392:296-300.
72. Yeh W.C., et al. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 2000, 12:633-642.
73. Takeda K., et al. Limb and skin abnormalities in mice lacking IKKalpha. Science 1999, 284:313-316.
74. Tanaka M., et al. Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity 1999, 10:421-429.
75. Schmidt-Supprian M., et al. NEMO/IKKγ-deficient mice model incontinentia pigmenti. Mol. Cell 2000, 5:981-992.
76. Rudolph D., et al. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev. 2000, 14:854-862.
77. Pasparakis M., et al. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 1996, 184:1397-1411.
78. Marino M.W., et al. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:8093-8098.
79. Rothe J., et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993, 364:798-802.
80. Cusson N., et al. The death domain kinase RIP protects thymocytes from tumor necrosis factor receptor type 2-induced cell death. J. Exp. Med. 2002, 196:15-26.
81. Yeh W.C., et al. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 1997, 7:715-725.
82. Ermolaeva M.A., et al. Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. Nat. Immunol. 2008, 9:1037-1046.
83. Prakash H., et al. Deficiency of XIAP leads to sensitization for Chlamydophila pneumoniae pulmonary infection and dysregulation of innate immune response in mice. J. Biol. Chem. 2010, 285:20291-20302.
84. Bauler L.D., et al. XIAP regulates cytosol-specific innate immunity to Listeria infection. PLoS Pathog. 2008, 4:e1000142.
85. Yabal M., et al. XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation. Cell Rep. 2014, 7:1796-1808.
86. Liang Y., Sundberg J.P. SHARPIN regulates mitochondria-dependent apoptosis in keratinocytes. J. Dermatol. Sci. 2011, 63:148-153.
87. Douglas T., et al. The inflammatory Caspases-1 and -11 mediate the pathogenesis of dermatitis in Sharpin-deficient mice. J. Immunol. 2015, 195:2365-2373.
88. Rodgers M.A., et al. The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation. J. Exp. Med. 2014, 211:1333-1347.
89. Emmerich C.H., et al. Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:15247-15252.
90. Shim J.H., et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 2005, 19:2668-2681.
91. Jadrich J.L., et al. The TGF beta activated kinase TAK1 regulates vascular development in vivo. Development 2006, 133:1529-1541.
92. Komatsu Y., et al. Targeted disruption of the Tab1 gene causes embryonic lethality and defects in cardiovascular and lung morphogenesis. Mech. Dev. 2002, 119:239-249.
93. Sanjo H., et al. TAB2 is essential for prevention of apoptosis in fetal liver but not for interleukin-1 signaling. Mol. Cell. Biol. 2003, 23:1231-1238.
94. Li Q., et al. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 1999, 13:1322-1328.
95. Li Q., et al. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 1999, 284:321-325.
96. Beg A.A., et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995, 376:167-170.
97. Alcamo E., et al. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment. J. Immunol. 2001, 167:1592-1600.
98. Barton D., et al. Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis. Eur. J. Immunol. 2000, 30:2323-2332.
99. He S., et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009, 137:1100-1111.
100. Mandal P., et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol. Cell 2014, 56:481-495.
101. Wu J., et al. Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res. 2013, 23:994-1006.
102. Bonnet M-C., et al. The adaptor protein FADD protects epidermal keratinocytes from necroptosis in-vivo and prevents skin inflammation. Immunity 2011, 35:572-582.
103. Kovalenko A., et al. Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. J. Exp. Med. 2009, 206:2161-2177.
104. Weinlich R., et al. Protective roles for caspase-8 and cFLIP in adult homeostasis. Cell Rep. 2013, 5:340-348.
105. Gunther C., et al. Caspase-8 controls the gut response to microbial challenges by Tnf-alpha-dependent and independent pathways. Gut 2015, 64:601-610.
106. Gunther C., et al. Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis. Nature 2011, 477:335-339.
107. Piao X., et al. c-FLIP maintains tissue homeostasis by preventing apoptosis and programmed necrosis. Sci. Signal. 2012, 5:ra93.
108. Kang T.B., et al. Caspase-8 serves both apoptotic and nonapoptotic roles. J. Immunol. 2004, 173:2976-2984.
109. Schattenberg J.M., et al. Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo. J. Hepatol. 2011, 55:1272-1280.
110. Salmena L., et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev. 2003, 17:883-895.
111. Zhang N., He Y.W. An essential role for c-FLIP in the efficient development of mature T lymphocytes. J. Exp. Med. 2005, 202:395-404.
112. Beisner D.R., et al. Cutting edge: innate immunity conferred by B cells is regulated by caspase-8. J. Immunol. 2005, 175:3469-3473.